Literature DB >> 3126853

Pancreatic cancer: the greatest oncological challenge.

R C Williamson1.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3126853      PMCID: PMC2545034          DOI: 10.1136/bmj.296.6620.445

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  16 in total

1.  The surgical treatment of pancreatic carcinoma.

Authors:  M Trede
Journal:  Surgery       Date:  1985-01       Impact factor: 3.982

2.  Carcinoma of the exocrine pancreas: a sex hormone responsive tumour?

Authors:  B A Greenway
Journal:  Br J Surg       Date:  1987-06       Impact factor: 6.939

3.  Surgical palliation of unresectable carcinoma of the pancreas.

Authors:  M G Sarr; J L Cameron
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

4.  Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy--an institutional perspective.

Authors:  J A van Heerden
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

5.  Endoscopic methods for relief of malignant obstructive jaundice.

Authors:  P B Cotton
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

6.  Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma.

Authors:  W U Shipley; W C Wood; J E Tepper; A L Warshaw; E L Orlow; S D Kaufman; G E Battit; G L Nardi
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

7.  Epidemiology of pancreatic cancer.

Authors:  L Gordis; E B Gold
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

8.  Treatment of unresectable pancreatic cancer.

Authors:  D C Carter
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-12

9.  Chemotherapy of pancreatic carcinoma.

Authors:  J H Harvey; P S Schein
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

10.  Relief of the pain of unresectable carcinoma of pancreas by chemical splanchnicectomy during laparotomy.

Authors:  A M Gardner; G Solomou
Journal:  Ann R Coll Surg Engl       Date:  1984-11       Impact factor: 1.891

View more
  19 in total

1.  ABO blood groups and cancer of the pancreas.

Authors:  V Annese; M Minervini; A Gabbrielli; G Gambassi; R Manna
Journal:  Int J Pancreatol       Date:  1990-03

2.  The challenge of pancreatic cancer.

Authors:  James L Abbruzzese
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.

Authors:  Peng Zhang; Zhiyong Guo; Ronglin Hu; Xiaoshun He; Xingyuan Jiao; Xiaofeng Zhu
Journal:  Tumour Biol       Date:  2015-07-08

Review 4.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

Review 5.  Pancreatic cancer: a review of emerging therapies.

Authors:  L Rosenberg
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

6.  Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study.

Authors:  Nicolas Tsavaris; Christos Kosmas; Helias Skopelitis; Panagiotis Gouveris; Petros Kopterides; Petros Kopteridis; Dioynissis Loukeris; Frantzeska Sigala; Alexandra Zorbala-Sypsa; Evangelos Felekouras; Efstathios Papalambros
Journal:  Invest New Drugs       Date:  2005-08       Impact factor: 3.850

7.  Prognostic value of histological grading in ductal adenocarcinoma of the pancreas. Klöppel vs TNM grading.

Authors:  P C Giulianotti; U Boggi; G Fornaciari; J Bruno; G Rossi; D Giardino; G Di Candio; F Mosca
Journal:  Int J Pancreatol       Date:  1995-06

8.  DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer.

Authors:  S Sciallero; W Giaretti; E Geido; L Bonelli; L Zhankui; S Saccomanno; E Zeraschi; V Pugliese
Journal:  Int J Pancreatol       Date:  1993-08

9.  Pancreatic cancer mortality in China (1991-2000).

Authors:  Li Wang; Gong-Huan Yang; Xing-Hua Lu; Zheng-Jing Huang; Hui Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study.

Authors:  T Cerny; G Martinelli; A Goldhirsch; F Terrier; R Joss; M F Fey; K W Brunner; A Küpfer
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.